Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric B Haura

Showing results (131-140 of 201) with videos related to

Pageof 21
Sort By:
Molecular Cancer Therapeutics|August 7, 2016
Preclinical Modeling of KIF5B-RET Fusion Lung AdenocarcinomaQingling Huang, Valentina E Schneeberger, Noreen Luetteke, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 27, 2016
A Sensitive NanoString-Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung AdenocarcinomaLu Chen, Brienne E Engel, Eric A Welsh, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2013
Dissection of TBK1 signaling via phosphoproteomics in lung cancer cellsJae-Young Kim, Eric A Welsh, Umut Oguz, et al.
Cancer Research|May 21, 2021
Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling NetworksIshwar N Kohale, Danielle M Burgenske, Ann C Mladek, et al.
Molecular Oncology|November 6, 2025
Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cellsJuhyeon Son, Lily L Remsing Rix, Bin Fang, et al.
Oncotarget|October 16, 2015
Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumorsElisa Baldelli, Guido Bellezza, Eric B Haura, et al.
Cell Chemical Biology|November 22, 2016
Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary TargetsClaire E Knezevic, Gabriela Wright, Lily L Remsing Rix, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2016
Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine ProteomicsScott M Haake, Jiannong Li, Yun Bai, et al.
Methods (San Diego, Calif.)|March 19, 2015
Evaluating kinase ATP uptake and tyrosine phosphorylation using multiplexed quantification of chemically labeled and post-translationally modified peptidesBin Fang, Melissa A Hoffman, Abu-Sayeef Mirza, et al.
Nature Communications|April 25, 2019
K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signalingQing Yin, Tao Han, Bin Fang, et al.
Pageof 21

Showing results (131-140 of 201) with videos related to

Sort By:
Pageof 21
Molecular Cancer Therapeutics|August 7, 2016
Preclinical Modeling of KIF5B-RET Fusion Lung AdenocarcinomaQingling Huang, Valentina E Schneeberger, Noreen Luetteke, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 27, 2016
A Sensitive NanoString-Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung AdenocarcinomaLu Chen, Brienne E Engel, Eric A Welsh, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2013
Dissection of TBK1 signaling via phosphoproteomics in lung cancer cellsJae-Young Kim, Eric A Welsh, Umut Oguz, et al.
Cancer Research|May 21, 2021
Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling NetworksIshwar N Kohale, Danielle M Burgenske, Ann C Mladek, et al.
Molecular Oncology|November 6, 2025
Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cellsJuhyeon Son, Lily L Remsing Rix, Bin Fang, et al.
Oncotarget|October 16, 2015
Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumorsElisa Baldelli, Guido Bellezza, Eric B Haura, et al.
Cell Chemical Biology|November 22, 2016
Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary TargetsClaire E Knezevic, Gabriela Wright, Lily L Remsing Rix, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2016
Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine ProteomicsScott M Haake, Jiannong Li, Yun Bai, et al.
Methods (San Diego, Calif.)|March 19, 2015
Evaluating kinase ATP uptake and tyrosine phosphorylation using multiplexed quantification of chemically labeled and post-translationally modified peptidesBin Fang, Melissa A Hoffman, Abu-Sayeef Mirza, et al.
Nature Communications|April 25, 2019
K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signalingQing Yin, Tao Han, Bin Fang, et al.
Pageof 21